VERADIGM INC. (formerly known as Allscripts Healthcare Solutions, Inc.) AND as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of February 5, 2024 TO THE INDENTURE Dated as of December 9, 2019First Supplemental Indenture • February 5th, 2024 • Veradigm Inc. • Services-computer integrated systems design • New York
Contract Type FiledFebruary 5th, 2024 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of February 5, 2024, between Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.), a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association (the “Trustee”), as trustee under the Indenture dated as of December 9, 2019, between the Company and the Trustee (the “Original Indenture” and, together with this Supplemental Indenture, each as may be amended and supplemented from time to time, the “Indenture”).
DATE: February 5, 2024 TO: Veradigm Inc. (f/k/a Allscripts Healthcare Solutions, Inc.) 222 Merchandise Mart Plaza, Suite 2024 Chicago, IL 60654 ATTENTION: General Counsel TELEPHONE: (312) 386-6751 EMAIL: legal.notices@veradigm.com FROM: Wells Fargo...Capped Call Transactions • February 5th, 2024 • Veradigm Inc. • Services-computer integrated systems design • New York
Contract Type FiledFebruary 5th, 2024 Company Industry JurisdictionThe parties hereto have previously entered into a letter agreement relating to a “Base Call Option Transaction” (the “Base Confirmation”) dated as of December 4, 2019 and an additional letter agreement relating to an “Additional Call Option Transaction” (the “Additional Confirmation” and, together with the Base Confirmation, each a “Confirmation”) dated as of December 18, 2019, the purpose of each of which was to confirm the terms and conditions of the capped call option transactions entered into between Wells Fargo Bank, National Association (“Dealer”) and Veradigm Inc. (f/k/a Allscripts Healthcare Solutions, Inc.) (“Counterparty”) in connection with the issuance by Counterparty of its 0.875% Convertible Senior Notes due 2027 (the “Convertible Notes” and each USD 1,000 principal amount of Convertible Notes, a “Convertible Note”). On February 5, 2024, Counterparty and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, entered into